Abstract
Purpose
Swimming pools can be a vector for transmission of adenovirus ocular infections. Polyhexamethylene biguanide (PHMB) is a disinfectant used in swimming pools and hot tubs. The current study determined whether PHMB is an effective disinfectant against ocular adenovirus serotypes at a concentration used to disinfect swimming pools and hot tubs.
Methods
The direct disinfecting activity of PHMB was determined in triplicate assays by incubating nine human adenovirus types (1, 2, 3, 4, 5, 7a, 8, 19, and 37) with 50 and 0 PPM (µg/ml) of PHMB for 24 hours at room temperature, to simulate swimming pool temperatures, or 40°C, to simulate hot tub temperatures. Plaque assays determined adenovirus titers after incubation. Titers were Log10 converted and mean ± standard deviation Log10 reductions from controls were calculated. Virucidal (greater than 99.9%) decreases in mean adenovirus titers after PHMB treatment were determined for each adenovirus type and temperature tested.
Results
At room temperature, 50 PPM of PHMB produced mean reductions in titers less than 1 Log10 for all adenovirus types tested. At 40°C, 50 PPM of PHMB produced mean reductions in titers less than 1 Log10 for two adenovirus types and greater than 1 Log10, but less than 3 Log10, for seven of nine adenovirus types.
Conclusions
50 PPM of PHMB was not virucidal against adenovirus at temperatures consistent with swimming pools or hot tubs.
Clinical Relevance
Recreational water maintained and sanitized with PHMB has the potential to serve as a vector for the transmission of ocular adenovirus infections.
INTRODUCTION
Adenovirus (Ad) ocular infections (epidemic keratoconjunctivitis [EKC], follicular conjunctivitis [FC], and pharyngeal conjunctival fever [PCF]) are the most commonly occurring ocular viral infections in the world1. These infections are known to occur in community and office based outbreaks1. Outbreaks of adenoviral ocular infections can be detrimental to the community because of the significant patient morbidity and the socioeconomic consequences of lost time from school and work1. Among the community based outbreaks, swimming pool water has been reported to be a vector for transmission2–10. Derrick first showed in 1943 that swimming pools can act as vectors for the transmission of “swimming bath conjunctivitis”2. The description of the patients’ symptoms suggested these were cases of pharyngeal conjunctival fever3. This observation came ten years before the first adenovirus was isolated11. Some of these swimming pool related outbreaks have been linked to inadequate chlorination of the swimming pool water5, 6, 9.
Proper maintenance and sanitization of recreational water is essential for the prevention of disease transmission. Chlorine is the most common sanitizing agent used in swimming pools. However, proper chlorination of swimming pool water has been associated with eye irritation in some people12. Eye irritation, chlorine maintenance, and other factors have led to the development of alternate, non-chlorine based agents to disinfect recreational water, such as swimming pools and hot tubs. One such agent is polyhexamethylene biguanide (PHMB).
PHMB is an effective public health biocide registered for numerous applications by the U.S. EPA under the Federal Insecticide, Fungicide, and Rodenticide Act, and supported under the Biocidal Products Directive in Europe12. It is unaffected by sunlight, water temperature, or pH fluctuations. This stability allows water to be properly maintained for longer periods, generally 7–14 days before additional PHMB is required13. PHMB is also used in ophthalmology as a topical treatment for Acanthamoeba keratitis14 and is an active antimicrobial agent in several multipurpose contact lens solutions15.
The use of PHMB for swimming pool and hot tub disinfection has led us to determine whether PHMB is an effective disinfectant against common ocular serotypes of adenovirus.
METHODS
Viruses and Cells
Clinical ocular adenovirus isolates of types 1, 2, 3, 4, 5, 7a, 8, and 19 were collected anonymously from patients presenting with typical adenoviral ocular disease at the Charles T. Campbell Ophthalmic Microbiology Laboratory at the UPMC Eye Center, University of Pittsburgh, Pittsburgh, PA and frozen at −70°C. The viruses are part of a retrospective clinical collection of adenovirus isolates. The isolates were de-identified and stored for diagnostic test validations. The serotypes of the adenovirus isolates were determined using serum neutralization. No clinical isolates of Ad37 were recovered, so the ATCC (American Type Culture Collection, Manassas, VA) reference strain of Ad37 was used. The types tested represent the most common adenovirus types that cause ocular infections (Ad8, Ad19, Ad37 cause EKC; Ad3, Ad4, Ad7a cause FC and PFC)1 and types that can replicate in rabbit ocular models (Ad1, Ad2, Ad5)16.
A549 Human Lung Carcinoma cells (CCL-185, ATCC) were used to prepare the adenovirus stocks and for the determination of viral titers for adenovirus. The A549 cells were grown and maintained in tissue culture media containing Eagle's MEM supplemented with 10% fetal bovine serum (Sigma Cell Culture Reagents, St. Louis, MO).
Experimental Agent
Polyhexamethylene biguanide hydrochloride (Baquacil® Sanitizer and Algistat Step 1, Arch Chemicals, Inc., Atlanta, GA) was purchased from a local swimming pool vendor in the Pittsburgh, PA area. The PHMB concentration in Baquacil® is 20%.
In Vitro Log Reduction Virucidal Assay
This study was conducted using triplicate assays with initial inocula of approximately 1.0 × 106 plaque forming units per milliliter (PFU/ml) of multiple clinical ocular isolates of Ad1, Ad2, Ad3, Ad4, Ad5, Ad7a, Ad19, and ATCC Ad37 and 1.0 × 104 PFU/ml of Ad8. Fifty µl of each of the test viruses were added to duplicate sets of 2 ml screw capped freezing tubes (Sarstedt, Inc., Newton, NC) containing 450 µl of 55.55 PPM (µg/ml) or 0 PPM of PHMB prepared in tissue culture media. This resulted in a final PHMB concentration of 50 PPM. Fifty PPM of PHMB was used as per the manufacturer’s instruction for recreational water disinfection. One set of tubes containing the virus/PHMB mixtures was incubated for 24 hours on the bench top at room temperature to simulate swimming pool conditions. The second set of tubes containing the virus/PHMB mixtures was incubated in a 40°C water bath for 24 hours to simulate hot tub conditions. After incubation, 500 µl of tissue culture media containing 20% fetal bovine serum (FBS) was added to each tube in preparation for the plaque assay.
Determination of Viral Titers (Plaque Assay)
Immediately after incubation and the addition of 500 µl of tissue culture media, the samples were serially diluted in tissue culture media containing 10% FBS for five 10-fold dilutions and inoculated in duplicate onto A549 cell monolayers in 24 well multiplates. After a 3 hour adsorption period, the wells were filled with tissue culture media containing 0.5% methylcellulose, except for Ad8 for which the wells were filled with standard tissue culture media. After 7–10 days incubation, the media was removed, the cells fixed and stained with 0.5% gentian violet solution containing formaldehyde, and the number of plaques counted using a dissecting microscope. The viral titers were calculated and expressed as PFU/ml.
Data Analysis
Viral titers were Log10 converted and Log10 differences in titers from the appropriate negative controls were calculated for each trial. The mean ± standard deviation Log10 differences in titers were calculated from the data of the three trials. A mean reduction in titer from the negative control of at least three Log10 (99.9% reduction) was considered a virucidal reduction.
RESULTS
The Effect of PHMB Treatment on Adenovirus Survival
The mean Log10 reductions from three trials of PHMB treatment on adenovirus survival at room temperature and 40°C are presented in Table 1. At room temperature, 50 PPM of PHMB produced no mean reductions of adenovirus titers greater than one Log10 for any of the adenovirus serotypes tested. At 40°C, 50 PPM of PHMB produced mean reductions in titers greater than two Log10, but less than three Log10, for Ad2, Ad3, Ad19, and Ad37. The mean reductions in titers for Ad1, Ad4, and Ad5 were greater than one Log10 but less than two Log10. The mean reduction in titer for the important ocular serotype of Ad7a approached a one Log10 (−0.91 ± 0.26 PFU/ml) reduction while 50 PPM of PHMB had no effect on Ad8 at 40°C. No virucidal reductions were demonstrated for 50 PPM of PHMB at both temperatures tested.
Table 1.
Mean ± Standard Deviation Log10 Differences in Adenoviral Titers from Control after PHMB Treatment.
Temperature | Ad1 | Ad2 | Ad3 | Ad4 | Ad5 | Ad7a | Ad8 | Ad19 | Ad37 |
---|---|---|---|---|---|---|---|---|---|
Room Temp | −0.69 ± 0.08 | −0.77 ± 0.47 | −0.37 ± 0.14 | −0.05 ± 0.08 | −0.72 ± 0.36 | +0.89 ± 0.55 | −0.27 ± 0.15 | −0.15 ± 0.14 | −0.23 ± 0.19 |
40°C | −1.30 ± 1.07 | −2.65 ± 0.23 | −2.36 ± 0.23 | −1.44 ± 0.40 | −1.57 ± 0.66 | −0.91 ± 0.26 | +0.13 ± 0.27 | −2.49 ± 1.47 | −2.60 ± 0.38 |
COMMENT
Adenoviruses are hardy viruses that have the ability to survive at least 8 weeks in a desiccated state17, 3–4 weeks in multi-dose bottles of topical fluorescein18, and at least five days in liquid transport media without a significant loss of infectivity after cross-country shipment19. The hardiness of adenoviruses may contribute to their ability to cause outbreaks of ocular infections. Therefore the disinfection of adenoviruses from potential vectors of transmission such as contaminated tomometer tips and ophthalmic instruments in the ophthalmologists’ offices and recreational water is of utmost importance to prevent transmission of disease.
Many disinfectants have been tested for their abilities to kill adenoviruses. Rutala and colleagues performed an extensive study evaluating the efficacy of a number of disinfectants against Ad820. They determined that 0.55% ortho-phthalaldehyde, 2.4% glutaraldehyde, 2.65% glutaraldehyde, 6,000 PPM chlorine, 1,900 PPM chlorine, 70% ethanol, 65% ethanol with 0.63% quaternary ammonium compound, 79.6% ethanol with 0.1% quaternary ammonium compound, and 0.2% peracetic acid were effective against Ad820. However other common disinfectants such as 70% isopropyl alcohol, 3% hydrogen peroxide, 4% chlorhexidine, and 10% povidone-iodine were ineffective against Ad820. However, these results may not extend to all adenovirus types since it is known that disinfectants have a range of efficacy against different adenovirus types21.
To date, there have been no studies evaluating the efficacy of PHMB for the disinfection of adenovirus. The results of this study demonstrated that at room temperature, 50 PPM of PHMB treatment produced no reductions of adenovirus titers greater than 1 Log10 for any of the adenovirus serotypes tested after 24 hours incubation. We conclude from these data that PHMB is an ineffective disinfectant for adenovirus at room temperature in concentrations used in swimming pools.
Fifty PPM of PHMB was more effective when the temperature was raised to 40°C. Fifty PPM of PHMB produced decreases in adenovirus titers greater than 1 Log10 for 7 of 9 adenovirus serotypes but did not demonstrate virucidal efficacy (99.9% reduction) against any of the adenovirus serotypes tested. However 50 PPM of PHMB had little or no effect on Ad7a and Ad8, which are two major causes of ocular adenovirus infections. From these data we conclude that PHMB may be more effective for some, but not all, adenovirus serotypes when the incubation temperature is raised to 40°C. Several factors may contribute to the increase in PHMB effectiveness at the higher temperature. Pinto, et al. demonstrated that exposure of the MS2 bacteriophage, used as a surrogate virus for non-enveloped mammalian viruses of which adenovirus is one, to PHMB resulted in the formation of viral aggregates. The aggregates were likely caused by changes in viral surface hydrophobicity. They concluded that the formation of these aggregates reduced the virucidal activity of PHMB22. A follow-up study by the same group and using the same virus demonstrated that by increasing the incubation temperature from 20°C to 40°C and 50°C, the viral aggregates decreased and the antiviral activity of PHMB increased23. These authors speculated that high temperatures may also produce conformational changes in the viral capsid that increase the sensitivity of viral nucleocapsids to PHMB23. These factors may have also contributed to an increase in effectiveness of PHMB against adenovirus at 40°C.
Based on the data from the current study, swimming pool water sanitized with PHMB would not effectively kill adenovirus contained in the water. Therefore, these swimming pools are a greater risk to act as vectors for the transmission of adenoviral ocular infections than those properly sanitized with an agent such as chlorine. Hot tub water may be more effectively sanitized with PHMB because the increased temperature increased the effectiveness of PHMB. However, PHMB was not effective against all the adenovirus serotypes tested therefore it may not be the optimal sanitizing agent for hot tub water.
These data are also important because PHMB is used as a disinfectant in several multipurpose contact lens solutions. The concentration of PHMB in these solutions is usually 0.0001% (1 µg/ml [PPM])15, which is 50× lower than the concentration tested in the current study. We previously demonstrated that contact lens solutions containing 0.0001% polyaminopropyl biguanide or 3% hydrogen peroxide solution were ineffective in sterilizing contact lenses infected with Ad8 and Ad1924. Based on the data in the current study, we predict the PHMB contained in multipurpose contact lens solutions would be ineffective for the disinfection of contact lenses contaminated with adenovirus. As the multipurpose contact lens solutions containing PHMB were not tested in this study, the disinfection efficacy of the formulated solutions against adenovirus remains unknown.
ACKNOWLEDGMENTS
Financial Support: NIH CORE Grant for Vision Research EY08098 (OVSRC), NIH Grant AI085570, The Eye and Ear Foundation of Pittsburgh, and Research to Prevent Blindness. RMQS was supported by a Career Development Award from Research to Prevent Blindness. The funding organizations had no role in the design or conduct of this research.
Footnotes
The Corresponding Author (EGR) of this manuscript containing original data confirms that he had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis as well as the decision to submit for publication.
This study was presented in part at the 2011 Ocular Microbiology and Immunology Group (OMIG) annual meeting, October 21, 2011 in Orlando, FL.
REFERENCES
- 1.Gordon JS, Aoki K, Kinchington PR. Adenovirus keratoconjunctivitis. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular Infection & Immunity. St Louis, MO: Mosby; 1996. pp. 877–894. [Google Scholar]
- 2.Derrick EH. Swimming bath conjunctivitis, with a report of 3 probable cases and a note on its epidemiology. Med J Australia. 1943;2:334–336. [Google Scholar]
- 3.Bell JA, Rowe WP, Engler JI, Parrott RH. Pharyngoconjunctival fever: Epidemiological studies of a recently recognized disease entity. JAMA. 1955;157(13):1083–1092. doi: 10.1001/jama.1955.02950300011003. [DOI] [PubMed] [Google Scholar]
- 4.Ormsby AL, Aitchison WS. The role of the swimming pool in the transmission of pharyngoconjunctival fever. Can Med Assoc J. 1955;73(11):864–866. [PMC free article] [PubMed] [Google Scholar]
- 5.Foy HM, Cooney MK, Halten JB. Adenovirus type 3 epidemic associated with intermittent chlorination of a swimming pool. Arch Environ Health. 1968;17(5):795–802. doi: 10.1080/00039896.1968.10665321. [DOI] [PubMed] [Google Scholar]
- 6.D'Angelo LJ, Hierholzer l, Keenlyside RA. Pharyngoconjunctival fever caused by adenovirus type 4: report of a swimming pool related outbreak with recovery of virus from pool water. J Infect Dis. 1979;140(1):42–47. doi: 10.1093/infdis/140.1.42. [DOI] [PubMed] [Google Scholar]
- 7.Martone WJ, Hierholzer JC, Keenlyside RA. An outbreak of adenovirus type 3 disease at a private recreation center swimming pool. Am J Epidemiol. 1980;111(2):229–237. doi: 10.1093/oxfordjournals.aje.a112890. [DOI] [PubMed] [Google Scholar]
- 8.Turner M, Istre G, Beauchamp H, Baum M, Arnold S. Community outbreak of adenovirus type 7a infections associated with swimming pool. South Med J. 1987;80(6):712–715. doi: 10.1097/00007611-198706000-00012. [DOI] [PubMed] [Google Scholar]
- 9.Papapetropoulou M, Vantarakis AC. Detection of adenovirus outbreak at a municipal swimming pool by nested PCR amplification. J lnfect. 1998;36(1):101–103. doi: 10.1016/s0163-4453(98)93414-4. [DOI] [PubMed] [Google Scholar]
- 10.Artieda J, Piñeiro L, González MC, et al. A swimming pool-related outbreak of pharyngoconjunctival fever in children due to adenovirus type 4, Gipuzkoa, Spain, 2008. Euro Surveill. 2009;14(8):6–9. [PubMed] [Google Scholar]
- 11.Rowe WP, Huebner RJ, Gilmore LK, Parrot RH, Ward TG. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med. 1953;84(3):570–573. doi: 10.3181/00379727-84-20714. [DOI] [PubMed] [Google Scholar]
- 12.Haag JR, Gieser RG. Effects of swimming pool water on the cornea. JAMA. 1983;249(18):2507–2508. [PubMed] [Google Scholar]
- 13.PHMB Product Stewardship Summary, April 2008. [accessed on June 13, 2012]; http://www.archchemicals.com/Fed/Corporate/Docs/ACC/ARCH_CHEMICALS-PHMB.pdf. [Google Scholar]
- 14.Larkin DF, Kilvington S, Dart JK. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmol. 1992;99(2):185–191. doi: 10.1016/s0161-6420(92)31994-3. [DOI] [PubMed] [Google Scholar]
- 15.Lucas AD, Gordon EA, Stratmeyer ME. Analysis of polyhexamethylene biguanide in multipurpose contact lens solutions. Talanta. 2009;80(2):1016–1019. doi: 10.1016/j.talanta.2009.07.031. [DOI] [PubMed] [Google Scholar]
- 16.Romanowski EG, Araullo-Cruz T, Gordon YJ. Multiple adenoviral serotypes demonstrate host range extension in the New Zealand rabbit ocular model. Invest Ophthalmol Vis Sci. 1998;39(3):532–536. [PubMed] [Google Scholar]
- 17.Gordon YJ, Gordon RY, Romanowski EG, Araullo-Cruz T. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmol. 1993;100(12):1835–1840. doi: 10.1016/s0161-6420(93)31389-8. [DOI] [PubMed] [Google Scholar]
- 18.Kowalski RP, Romanowski EG, Waikom B, Gordon YJ. The survival of adenovirus in multidose bottles of topical fluorescein. Am J Ophthalmol. 1998;126(6):835–836. doi: 10.1016/s0002-9394(98)00252-9. [DOI] [PubMed] [Google Scholar]
- 19.Romanowski EG, Bartels SP, Vogel R, et al. Feasibility of an antiviral clinical trial requiring cross-country shipment of conjunctival adenovirus cultures and recovery of infectious virus. Cur Eye Res. 2004;29(2–3):195–199. doi: 10.1080/02713680490504830. [DOI] [PubMed] [Google Scholar]
- 20.Rutala WA, Peacock JE, Gergen MF, Sobsey MD, Weber DJ. Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities. Antimicrob Agents Chemother. 2006;50(4):1419–1424. doi: 10.1128/AAC.50.4.1419-1424.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Sauerbrei A, Sehr K, Brandstädt A, Heim A, Reimer K, Wutzler P. Sensitivity of human adenoviruses to different groups of chemical biocides. J Hosp Infect. 2004;57(1):59–66. doi: 10.1016/j.jhin.2004.01.022. [DOI] [PubMed] [Google Scholar]
- 22.Pinto F, Maillard JY, Denyer SP, McGeechan P. Polyhexamethylene biguanide exposure leads to viral aggregation. J Appl Microbiol. 2010;108(6):1880–1888. doi: 10.1111/j.1365-2672.2009.04596.x. [DOI] [PubMed] [Google Scholar]
- 23.Pinto F, Maillard JY, Denyer SP. Effect of surfactants, temperature, and sonication on the virucidal activity of polyhexamethylene biguanide against the bacteriophage MS2. Am J Infect Control. 2010;38(5):393–398. doi: 10.1016/j.ajic.2009.08.012. [DOI] [PubMed] [Google Scholar]
- 24.Kowalski RP, Sundar-Raj CV, Romanowski EG, Gordon YJ. The disinfection of contact lenses contaminated with adenovirus. Am J Ophthalmol. 2001;132(5):777–779. doi: 10.1016/s0002-9394(01)01128-x. [DOI] [PubMed] [Google Scholar]